Effect of serum separator blood collection tubes on drug concentrations.
Quattrocchi F, Karnes HT, Robinson JD, Hendeles L
Purpose
Conclusion
Studies (2)
Purpose
The purpose of this study was to determine the effects of collection container and storage on serum levels of therapeutic drugs in patient specimens. All specimens were frozen until analysis.
Summary of Findings
When blood was collected in SST, there were decreases in serum concentrations of lidocaine (22.8%, p<0.004), pentobarbital (12.7%, p<0.0004), and phenytoin (10.6%, p<0.002), but not chloramphenicol, digoxin, gentamicin, phenobarbital, quinidine, theophylline, or tobramycin compared with specimens collected in Vacutainer or micro polypropylene tubes. When serum was transferred into new SST every day over 5 days of refrigerated storage, concentrations of phenytoin decreased by 57%.
Biospecimens
FluidBloodFluidSerumPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
Small moleculeImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Patient age AdultChildBiospecimen Acquisition Type of collection container/solution Micro SSTPolypropylene tubeRed Vacutainer tubeSSTBiospecimen Aliquots and Components Blood and blood products SerumWhole bloodStorage Storage duration 0 days1 day2 days3 days4 days5 daysStorage Storage temperature RefrigeratedStorage Type of storage container Plain glass tubeSST
Purpose
The purpose of this study was to determine the effects of storage, specimen volume, and initial concentration on levels of phenytoin and valproic acid in serum. Blood from a healthy volunteer was spiked with phenytoin and valproic acid. All serum specimens were frozen until analysis.
Summary of Findings
When blood was stored for 5 h in SST, there were significant decreases in phenytoin levels and a trend toward decreased valproic acid in serum. The change in phenytoin levels strongly correlated with the storage duration (r=0.94, p<0.01). The storage-related decline in phenytoin levels decreased as specimen volume increased. Initial phenytoin concentration had no influence on the storage-related decline.
Biospecimens
FluidBloodFluidSerumPreservation Types
FrozenDiagnoses
NormalPlatforms
Small moleculeImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level 12.5 ug/mL phenytoin18.8 ug/mL phenytoin25 ug/mL phenytoin3.1 ug/mL phenytoin6.3 ug/mL phenytoinBiospecimen Aliquots and Components Aliquot size/volume 0.5 mL1.0 mL2.0 mL4.0 mL6.0 mLBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Storage duration 1 h15 min2 h3 h4 h5 hStorage Type of storage container SSTVacutainer tube